Projects funded by the NCN

Investigation of the mechanisms of the neuroprotective effect of group II metabotropic receptors (mGluR2/3) agonist in a...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: dr Ewelina Bratek

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

New mulitple target-directed ligands - A1/A2A adenosine receptors antagonists and monoamine oxidase B inhibitors - searc...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Michał Załuski

Uniwersytet Jagielloński, Collegium Medicum, Wydział Farmaceutyczny

A comparison of neuroprotective features of human mesenchymal stem cells (MSC) derived from adult (bon marrow) and neona...

Call: OPUS 1 , Panel: NZ3

Principal investigator: prof. Krystyna Domańska-Janik

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

The influence of body temperature during perinatal hypoxia on the level of neurotrophic-derived factor (BDNF) - new appr...

Call: PRELUDIUM 11 , Panel: NZ7

Principal investigator: Hanna Kletkiewicz

Uniwersytet Mikołaja Kopernika, Wydział Biologii i Ochrony Środowiska

In Search for the novel therapeutic strategies in the treatment of brain ischemia. Determination of the neuroprotective ...

Call: SONATA 11 , Panel: NZ4

Principal investigator: dr Bartosz Pomierny

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Counteraction Parkinson's disease by application of progressive vibration training in humans and evaluation of factors w...

Call: SONATA 1 , Panel: NZ7

Principal investigator: dr Anna Gąsiorowska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

The influence of a new hybryd compound derived from 2-(2,5-dioxopyrrolidin-1-yl) propanamide on hippocampal neuroprotect...

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr hab. Marta Andres-Mach

Instytut Medycyny Wsi im. Witolda Chodźki

Neuroprotective role of the GPR39 receptor in the central nervous system. Its relationship to Alzheimer Disease.

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Młyniec

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny